Program

8:00 AM – 10:00 AM Plenary Session 1: Family Care and Communication

8:00 AM – 8:20 AM Bereavement Centered Care
Charles Corr, PhD, USA

8:20 AM – 8:40 AM Dual Advocacy: A Value-Positive Approach to Obtaining Consent for Organ Donation
Patricia Mulvania, BSN, USA

8:40 AM – 9:00 AM Consent for Donation, The European Way
Leo Roels, BS, CPTC, Belgium

Q & A

9:10 AM – 10:00 AM Oral Abstract Presentations: Consent

9:10 AM AT DONOR FAMILIES CAN TEACH US ABOUT CONSENT: DONOR FAMILY VIDEO INTERVIEWS. (Abstract #1)
Lisa Dinhofer. Frederick, MD, USA.

9:20 AM A STRATEGY TO RE-APPROACH FAMILY DECLINES INCREASES CONSENT RATES. (Abstract #2)
Gigi Vulgamott, Laura Schons, John Sommerauer. Westwood, KS; Kansas City, MO, USA.

9:30 AM PEDIATRIC ORGAN DONATION: WHAT FACTORS MOST INFLUENCE PARENTS’ DONATION DECISIONS? (Abstract #3)
James R. Rodrigue, Danielle L. Cornell, Richard J. Howard. Boston, MA; Gainesville, FL, USA.

9:40 AM THE STABILITY OF ORGAN DONATION DECISIONS BY NEXT-OF-KIN AND FACTORS THAT PREDICT IT. (Abstract #4)
James R. Rodrigue, Danielle L. Cornell, Richard J. Howard. Boston, MA; Gainesville, FL, USA.

9:50 AM DONATION DECISION – FAMILIES ELABORATE ON FACTORS SURROUNDING THEIR DECISION TO DONATE. (Abstract #5)
Jennifer Gillott, Geoff White. Sydney, New South Wales; Melbourne, Victoria, Australia.

10:15 AM – 12:30 PM Plenary Session 2: Hospital Development: Breakthrough Collaborative and Other Initiatives, What’s Working?

10:20 AM – 10:40 PM The U.S. Organ Donation and Transplantation Breakthrough Collaborative Experience
Virginia McBride, RN, MPH, CPTC, USA

10:40 AM – 11:00 PM Canada Breakthrough Collaborative
Kim Young, Canada

11:00 AM – 11:20 PM The Donor Action Program: Roadmap to Success
Caroline Gachet, Switzerland

Q & A

11:30 AM – 12:30 PM Oral Abstract Presentations: Hospital Development

11:30 AM INTRODUCING DashTrack©, THE DASHBOARD MADE EASY. (Abstract #6)
Hedi Aguiar, Seung W. Lee, Maria Stadtler, Tom Mone, Esther-Marie Carmichael. Los Angeles, CA, USA.

11:42 AM A NEW HOSPITAL SERVICES SERVICE MODEL. (Abstract #7)
Esther-Marie Carmichael, Hedi Aguiar, Maria Stadtler. Los Angeles, CA, USA.

11:54 AM REMOTE DSA HOSPITAL IMPROVEMENTS. (Abstract #8)
Dorothy Starr, Shante Wells. Austin, TX, USA.

12:06 PM ESTIMATING TISSUE DONATION POTENTIAL OUTSIDE THE ACUTE CARE SETTING. (Abstract #9)
Kimberly Young, Simon Avis, Karen Hornby, Christina Rogers. Edmonton, AB, Canada.

12:18 PM OPO STRATEGY FOR TIMELY NOTIFICATION OF POTENTIAL ORGAN DONORS DRAMATICALLY IMPACTS CONVERION RATES. (Abstract #10)
Gweneth D. George, Sharon M. West, Richard M. Hasz, Howard M. Nathan. Philadelphia, PA, USA.

1:30 PM – 3:10 PM Concurrent Session 1: Tissue Donation/Recovery/Processing Update on European and US Regulations and Standards

1:30 PM – 1:50 PM The European Experience
Ruth Warwick, MD, UK

1:50 PM – 2:10 PM The U.S. Experience
Scott Brubaker, CTBS, USA

2:10 PM – 2:30 PM Case Studies: Interactive Session with Panel & Participants

Q & A

2:30 PM – 3:10 PM Oral Abstract Presentations: Tissue Banking

2:30 PM CRTICAL CARE AND OPERATING ROOM NURSES’ PERCEPTIONS TOWARDS ORGAN AND TISSUE DONATION. (Abstract #11)
Beatrice Pelleriaux, Denis Dufrane. Brussels, Belgium.

2:40 PM EVALUATING THE PROCESS OF DONATION: SURVEY WITH 100 CORNEA DONOR RELATIVES. (Abstract #12)
Valter D. Garcia, Adriana P. Barboza, Fernanda L. Tolvez, Rita C. Pereira. Porto Alegre, Brazil.

2:50 PM HOW EFFECTIVE ARE HEART VALVE TRANSPLANTS FROM DONORS OVER 65 YEARS OF AGE? (Abstract #13)
Katharina Grosse, Rudolf Meyer, Roland Hetzer, Erna Schmitzer, Onur Kuecuek, Frank Polster, Claus Wesslau. Berlin, Germany.

3:00 PM EVALUATION OF SURGICAL BONE BANKING IN CANADA. (Abstract #14)
Kimberly Young, James W. Mohr, Marc Germain, Christina Rogers. Edmonton, AB, Canada.

1:30 PM – 3:10 PM Concurrent Session 2: Professional Support for the Transplant Coordinator,What’s Available, What’s Coming?

Systems for Clinical Donor Tracking
Todd Jennings, USA
Mike Smith, Netherlands

DonorNet 2007: What is it and How Does it Work?
Richard D. Hasz, MFS, CPTC, USA

Q & A

2:30 PM – 3:10 PM Oral Abstract Presentations: Coordinator Education

2:30 PM TRAINING OF TRANSPLANT EDUCATIONAL COORDINATORS – INITIAL EXPERIENCE IN BRAZIL. (Abstract #15)
Valter D. Garcia, Clotilde D. Garcia, Elizete Keitel, Lisiane Picasso, Adriana P. Barboza, Paulo Rene. Porto Alegre, Brazil.

2:40 PM INTERNATIONALITY AS THE TRAINING BEST FEATURE. (Abstract #16)
Gloria Paez, Ricard Valero, Marti Manyalich. Barcelona, Spain.

2:50 PM HEALTH CARE PROFESSIONALS – WHAT DO THEY KNOW ABOUT ORGAN DONATION? (Abstract #17)
Teresa Pont, Núria Masnou, Rosa Maria Gràcia, Pere Salamero, Roser Deulofeu. Barcelona, Spain.

3:10 PM TISSUE PROCESSING DIRECTLY CONDITIONED CLINICAL APPLICATIONS: FRESH FROZEN VS. CHEMICALLY TREATED FREEZE-DRIED FASCIA LATA. (Abstract #5.5)
Denis Dufrane, Beatrice Pelleriaux, Olivier Cornu, Christian Delloye. Brussels, Belgium.

3:30 PM – 4:50 PM Plenary Session 3: Donor Maintenance

3:30 PM – 3:50 PM Optimizing the Yield of Thoracic Organs
Wayne Babcock, RN, BSN, CPTC, USA

Q & A

4:00 PM INCIDENTAL RENAL CELL CARCINOMA IN BRAIN DEAD ORGAN DONORS.(Abstract #19)
Kerstin Moench, Christian Moench, Fernando Bittinger, Jochen Thies, Dietmar Mauer. Middle Region; Frankfurt/Main; Mainz, Germany.

4:12 PM TO ACCEPT OR NOT TO ACCEPT: ARE CURRENT CRITERIA FOR LUNG DONATION STILL OPTIMAL OR SHOULD THEY BE REVISED? (Abstract #20)
Marion Nicke, Andre Simon, Nils Fruehauf. Hannover, Niedersachsen, Germany.

4:24 PM RECENT, 5-YEAR HCV SEROPREVALANCE TREND AMONG CADAVERIC ORGAN DONORS IN CALIFORNIA. (Abstract #21)
Marek J. Nowicki, Dem Brucal, Eugene Osborne, Helen Nelson, Tom Mone, Robert Mendez. Los Angeles, CA; Oakland, CA; Sacramento, CA, USA.

4:36 PM SIGNIFICANT REDUCTION OF PROINFLAMMATORY CYTOKINES BY TREATMENT OF THE HUMAN BRAIN DEAD DONOR – A PROSPECTIVE RANDOMIZED TRIAL. (Abstract #22)
Onur Kuecuek, Johann Pratschke, Katharina Grosse, Sven Jonas, Andreas Pascher, Sascha Weiss, Peter Neuhaus, Claus Wesslau. Berlin, Germany.

4:50 PM – 6:00 PM Plenary Session 4: Organ Preservation

4:50 PM – 5:10 PM Back to the Future: Machine Perfusion
Henri Leuvenink, Netherlands

Q & A

5:10 PM – 6:00 PM Oral Abstract Presentations: Preservation

5:10 PM CAN MACHINE PERFUSION DECREASE THE LIKELIHOOD OF KIDNEY DISCARD? (Abstract #23)
Yong W. Cho, Suphamai Bunnapradist, Maria Stadtler, Vicki Simmons, Jim Locke, Thomas Mone, Robert Mendez, Tariq Shah. Los Angeles, CA, USA.

5:20 PM DOES CALCIUM CHANNEL BLOCKER IMPROVEMENT OF PERFUSION IMPACT FOR FUNCTIONING KIDNEY GRAFT IN EARLY PERIOD AFTER TRANSPLANTATION? (Abstract #24)
Maciej Nowacki, Marek Ostrowski, Maciej Romanowski, Jerzy Sienko, Tadeusz Sulikowski. Szczecin, Poland.

5:30 PM PRESERVATION OF KIDNEY GRAFTS USING THE AIRDRIVE, A NOVEL DISPOSABLE PERFUSION SYSTEM; PRELIMINARY RESULTS. (Abstract #25)
Marie-Claire J.M. Schreinemachers, Benedict M. Doorschodt, Mario Sitzia, Thomas M. Van Gulik, Rene H. Tolba. Amsterdam, Netherlands; Bonn, Germany.

5:40 PM BENEFICIAL EFFECT OF U-74389G ON RENAL TISSUE IN AN EXPERIMENTAL MODEL OF ISCHEMIA/REPERFUSION INJURY OF THE KIDNEY IN RATS. (Abstract #26)
Apostolos Papalois, Constantina Papadopoulou, Periklis Tzardis, Marina Kontogiorgi, Ioannis Sfiniadakis, Evangelos Felekouras, Emmanuel Leandros, George Zografos, Ioannis Bramis, Elias Bastounis. Pikermi, Athens; Athens, Greece.

5:50 PM COLD ISCHEMIA DETERMINANTES ACUTE REJECTION AND LONG-TERM GRAFT LOSS BUT NOT DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION, IN THE MODERN IMMUNOSUPPRESSION ERA. (Abstract #27)
Dimitri Mikhalski, Karl Martin Wissing, Nilufer Broeders, Pierre Vereestraeten, Anh Dung Hoang, Valerio Lucidi, Florance Hut, Patricia Loi, Fredi Mboti, Alexis Buggenhout, Vincent Donckier, Daniel Abramowicz. Brussels, Belgium.

6:00 PM – 7:30 PM Congress Welcome Reception - “Taste of Philadelphia”
Exhibits Open

7:50 AM – 8:00 AM Welcome and Opening Remarks
Valter Duro Garcia, ISODP President
Howard M. Nathan, ISODP 2007 Congress Program Chair, ISODP Incoming President

8:00 AM – 9:30 AM Plenary Symposium I: ECD Organs: Risks, Outcomes, Financial Implications, Ethical and Legal Aspects
Joint ITCS and ISODP Session

U.S. Outcomes from the SRTR: Kidney, Liver, Heart
Alan Leichtman, MD USA

Economics in the Use of ECD Organs
David A. Axelrod, MD, USA

Donor Factors Influencing Graft Survival
Bernard Loty, MD, PhD, France

Question and Answer

10:00 AM – 11:00 AM Plenary Symposium II: Living Donation and Transplant Tourism

Transplant Tourism as a Special Case of Medical Tourism
Roger W. Evans, PhD, USA

An Inside Look at Transplant Tourism as a Global Industry
Aruna Th-Hollingshead, BHA, BHM Canada

Transplant Tourism is an Unavoidable Consequence of the Present System that Could be Diminished by Incentives to Increase Donations
Luis Tomatis, MD, FACS, FACC, USA

Question and Answer

11:00 AM – 12:10 PM Panel Discussion: Challenges in Deceased Organ Donation - Global Perspectives

Perspectives from China
Klaus Chen, PhD, China

Perspectives from Singapore
Anantharaman Vásthala, Singapore

The Organ Donation System in Israel – Innovations and Disappointments
Jonathan Cohen, MD, Israel

Question and Answer

12:10 PM – 1:10 PM Lunch Session - Training Transplant Professionals Around the World (optional)

Transplant Procurement Management (TPM)
Gloria Paez, RN, MSN, Spain

North American Transplant Coordinators Organization (NATCO)
Jan Finn, RN, MSN, USA

Gift of Life Institute
Howard M. Nathan, USA

2:25 PM – 3:25 PM Concurrent Oral Abstract Presentations I

1.) Expanded Criteria Donor - Liver I

2:25 PM SEVERE HYPERNATREMIA IN DECEASED LIVER DONORS DOES NOT INCREASE THE RATE OF PRIMARY NON-FUNCTION. (Abstract #28)
Richard S. Mangus, Jonathan A. Fridell, Rodrigo M. Vianna, Jared Anderson, A. Joseph Tector. Indianapolis, IN, USA.

2:37 PM EXPANDING THE DONOR POOL BY USING TRAUMATIZED LIVER GRAFTS? A SINGLE CENTER EXPERIENCE. (Abstract #29)
Roberta Bova, Matthias Glanemann, Jan M. Langrehr, Peter Neuhaus. Berlin, Germany.

2:49 PM USE OF SEVERELY OBESE DECEASED DONORS IN LIVER TRANSPLANTATION: RAPID RESOLUTION OF STEATOSIS IN THE POST-TRANSPLANT PERIOD. (Abstract #30)
Richard S. Mangus, Jonathan A. Fridell, Rodrigo M. Vianna, Chelsea R. Vandenboom, A. Joseph Tector. Indianapolis, IN, USA.

3:01 PM EXPANDED CRITERIA LIVER DONORS (ECD): EFFECT OF CUMULATIVE RISKS. (Abstract #31)
Carl-Ludwig Fischer-Froehlich, Werner Lauchart. Stuttgart, Germany.

3:13 PM WHY DO OLDER DONOR LIVERS FAIL? AN ANALYSIS OF LIVER ALLOGRAFTS FROM DONORS OVER AGE 60. (Abstract #32)
Richard S. Mangus, Jonathan A. Fridell, Rodrigo M. Vianna, Terra R. Pearson, A. Joseph Tector. Indianapolis, IN, USA.

2.) Expanded Criteria Donor - Kidney

2:25 PM HOW ACCURATE ARE FROZEN SECTION BIOPSIES OF DECEASED DONOR KIDNEYS? (Abstract #33)
Scott A. Ames, Steven Dikman, Eric B. Grossman, Enver Akalin, Susan Lerner, Jonathan S. Bromberg. New York, NY, USA.

2:37 PM DUAL KIDNEY TRANSPLANTS FROM VERY OLD OR VERY YOUNG DONORS; OUTCOMES AND COMPLICATIONS. (Abstract #34)
Mark R. Laftavi, Mahmood Kulaylate, Romesh Kohli, Mohammad Ibrahim, Oleh G. Pankewycz. Buffalo, NY, USA.27 Sunday, March 18

2:49 PM ASSESSMENT OF DECEASED DONOR KIDNEYS BY PROTEINURIA. (Abstract #35)
Mirian Opgenoorth, Andreas Reif, Detlev Boesesebeck, Christian Hugo. Munich, Bavaria; Erlangen, Bavaria, Germany.

3:01 PM FACTORS ASSOCIATED WITH DISCARD OF RECOVERED KIDNEYS. (Abstract #36)
Yong W. Cho, Tariq Shah, Maria Stadtler, Vicki Simmons, Renee Hawthorne, Thomas Mone, Robert Mendez, Suphamai Bunnapradist. Los Angeles, CA, USA.

3:13 PM GRAFT LOSS IN KIDNEY TRANSPLANTATION USING EXPANDED CRITERIA DONORS: A MULTIVARIATE RISK FACTOR ANALYSIS. (Abstract #37)
Rajinder P. Singh, Philip Moore, Alan Farney, Jeffrey Rogers, Erica L. Hartmann, Amber Reeves-Daniel, Michael Gautreaux, Samy Iskandar, Patricia L. Adams, Robert J. Stratta. Winston-Salem, NC, USA.

3.) Minority Issues

2:25 PM EVOLUTION OF A 20 YEAR DATA ANALYSIS OF A NATIONAL DONOR EDUCATION PROGRAM. (Abstract #38)
Clive O. Callender, Patrice V. Miles. Washington, DC, USA.

2:37 PM BLACKS AS DONORS FOR TRANSPLANTATION: SUBOPTIMAL OUTCOMES OVERCOME BY TRANSPLANTATION INTO OTHER MINORITIES. (Abstract #39)
Clive O. Callender, Wida S. Cherikh, Patrice V. Miles, Margruetta B. Hall. Washington, DC; Richmond, VA, USA.

2:49 PM HISPANIC ORGAN DONATION: IMPACT OF TWO MASS MEDIA COMMUNITY CAMPAIGNS. (Abstract #40)
Sara Pace Jones, Stacy Alvarez-Underwood, Eusebio M. Alvaro, Jason T. Siegel. Phoenix, AZ; Claremont, CA, USA.

3:01 PM CULTURALLY COMPETENT METHODS TO PROMOTE ORGAN DONATION AMONG AFRICAN AMERICANS (AA) USING VENUES OF THE BUREAU OF MOTOR VEHICLES (BMV).(Abstract #41)
Carlumandarlo E. Zaramo, Charles S. Modlin, Toni Morton, Gordon Bowen, Jeanine Carroll. Richmond Hts., OH; Cleveland, OH, USA.

3:13 PM A NOVEL HOME-BASED EDUCATIONAL PROGRAM TO INCREASE LIVE DONOR KIDNEY TRANSPLANTATION. (Abstract #42)
James R. Rodrigue, Danielle L. Cornell, Bruce Kaplan, Richard J. Howard. Boston, MA; Gainesville, FL; Chicago, IL, USA.

4.) Global Perspectives

2:25 PM A SOCIO-ECONOMIC SURVEY OF KIDNEY VENDORS IN PAKISTAN. (Abstract #43)
S.A.A. Naqvi, Bux Ali, Farida Mazhar, M.N. Zafar, S.A.H. Rizvi. Karachi, Pakistan.

2:37 PM REGULATED UNRELATED LIVING DONATION AND TRANSPLANT TOURISM: EFFECT ON LIVING-RALATED DONOR TRANSPLANTATION AND DECEASED DONATION IN ISRAEL. (Abstract #44)
Eytan Mor, Rachel Michowitz. Petah-Tiqwa, Israel.

2:49 PM RENAL TRANSPLANTATION IN LATIN AMERICA. (Abstract #45)
Valter D. Garcia, Jose Osmar M. Pestana, Eduardo Santiago-Delpin. Porto Alegre, Brazil.

3:01 PM EPIDEMIOLOGY OF BRAIN DEATH AND ORGAN DONATION IN SAUDI ARABIA. (Abstract #46)
Besher Al Attar, Faissal A.M. Shaheen, Abdulqayoum M.S. Babiker, Haroun Z. Ahmed, Levi L. Saclayan. Riyadh, Saudi Arabia.

3:13 PM ORGAN DONATION IN GERMANY – PERSPECTIVES TO INCREASE POST MORTEM ORGAN DONATION. (Abstract #47)
Franz Schaub, Claus Wesslau, Guenter Kirste. Neu-Isenburg, Germany.

4:00 PM – 5:36 PM Oral Abstract Presentations 2

5.) Expanded Criteria Donor - Liver II

4:00 PM USE OF HIGH DONOR RISK INDEX LIVER GRAFTS LEADS TO INCREASED GRAFT LOSS AFTER LIVER RETRANSPLANTATION. (Abstract #48)
Cosme Manzarbeitia, Barbara Aguilar, Kenneth Rothstein, Victor Araya, Mauricio Orrego, Santiago Munoz, Adina Osband, David J. Reich. Philadelphia, PA, USA.

4:12 PM POSITIVE IMPLICATION OF APPLYING EXTENDED DONOR CRITERIA IN LIVER TRANSPLANTATION. (Abstract #49)
Arash Nickkholgh, Peter Schemmer, Ulf Hinz, Till Gerling, Peter Sauer, Jens Encke, Jürgen Weitz, Markus W. Büchler, Jan Schmidt. Heidelberg, Germany; Leiden, Netherlands.28

4:24 PM UTILIZATION OF HTLV SEROLOGY POSITIVE ALLOGRAFTS FOR LIVER TRANSPLANTATION. (Abstract #50)
Irene J. Lo, Barbara Alkofer, Cindy Kin, James V. Guarrera, Benjamin Samstein, Dominique Jan, Michael Schilsky, Samuel Sigal, Lorna Dove, Paul Gaglio, Robert Brown, Jean C. Emond, John F. Renz. New York, NY, USA.

4:36 PM USE OF HEPATITIS C-INFECTED DECEASED DONORS IN LIVER TRANSPLANTATION: A CASE CONTROL STUDY. (Abstract #51)
Richard S. Mangus, Paul Y. Kwo, Sydney Wilson, Jonathan A. Fridell, Rodrigo M. Vianna, A. Joseph Tector. Indianapolis, IN, USA.

4:48 PM LIVER TRANSPLANTATION (LT) USING DONORS POSITIVE FOR HTLV I/II – REPORT OF UNOS REGISTRY DATA. (Abstract #52)
Michael R. Marvin, Kwadwo Kwarteng, Guy N. Brock, Kadiyala V. Ravindra, Mary Eng, Joseph F. Buell. Lousiville, KY; Louisville, KY, USA.

5:00 PM EFFECTIVE REGIONAL SHARING OF SPLIT LIVER GRAFTS. (Abstract #53)
Meghna V. Misra, Jordan R. Gutweiler, Matthew Y. Suh, Laura E. Krawczuk, Roger L. Jenkins, Craig W. Lillehei, Maureen M. Jonas, Heung Bae Kim. Boston, MA; Burlington, MA, USA.

5:12 PM FLUORESCENCE SPECTROSCOPY AS A METHOD FOR THE DIAGNOSIS OF HEPATIC STEATOSIS. (Abstract #54)
Gustavo R. Oliveira, Orlando Castro-e-Silva, Ajith K. Sankarankutty, Juliana Ferreira, Cristina Kurachi, Sergio Zucoloto, Vanderlei S. Bagnato. Sao Carlos/Ribeirao Preto, Sao Paulo, Brazil.

5:24 PM OF EXTENDED SEROLOGIC TESTING IN ANTI-HBc POSITIVE LIVER DONORS. (Abstract #55)
Carl-Ludwig Fischer-Froehlich, Werner Lauchart. Stuttgart, Germany.

6.) Organ Allocation

4:00 PM VIRTUAL CROSSMATCH IMPROVES ORGAN ALLOCATION IN SENSITIZED PATIENTS.(Abstract #56)
Robin Waxman, M.B. Hagan, Josef Stehlik, Matthew Movsesian, Bhava Reddy, Michael E. Gilbert, A.G. Kfoury, Dale Renlund, Feras Bader, David Bull, Anne Fuller, M.E. Hammond, Nauman Islam, David Eckels. SLC, UT, USA.

4:12 PM CONSEQUENCES OF ALLOCATING DECEASED DONOR ORGANS BASED ON RECIPIENT ANTIBODY SPECIFICITIES (CPRA). (Abstract #57)
Ronald H. Kerman, Charles T. Van Buren, Stephen M. Katz, Stan Stepkowski, Teresa Shafer, Carolyn Olivarez, Barry D. Kahan. Houston, TX, USA.

4:24 PM SHOULD KIDNEYS FROM ZERO-ANTIGEN MISMATCH EXPANDED CRITERIA DONORS BE SHARED? (Abstract #58)
Rajinder P. Singh, Alan Farney, Jeffrey Rogers, Michael D. Gautreaux, Erica L. Hartmann, Amber Reeves-Daniel, David F. Kiger, Samy S. Iskandar, Patricia L. Adams, Robert J. Stratta. Winston-Salem, NC, USA.

4:36 PM KIDNEY ALLOCATION IN CANADA: CONSENSUS RECOMMENDATIONS FROM THE 2006 FORUM. (Abstract #59)
Kimberly Young, Greg Knoll, Tracy Brand. Edmonton, AB, Canada.

4:48 PM TREAT THE KIDNEY LIKE A HEART – USING DISTRIBUTION TIMES TO IMPROVE RENAL ALLOCATION. (Abstract #60)
J. Abrams, L. Suplee, D. Agres, P. Sammut, R. Hasz, H. Nathan, S. West, S. Doll. Phila, PA, USA.

5:00 PM NO DIFFERENCE IN INITIAL OR LONG-TERM OUTCOME FOR LIVERS PROCURED LOCALLY AND THOSE SHARED REGIONALLY AND NATIONALLY. (Abstract #61)
Richard S. Mangus, Jonathan A. Fridell, Rodrigo M. Vianna, Jay Read, A. Joseph Tector. Indianapolis, IN, USA.

5:12 PM THE ISSUE OF RESCUE ALLOCATION IN LIVER TRANSPLANTATION WITHIN EUROTRANSPLANT AREA: HEIDELBERG EXPERIENCE. (Abstract #62)
Arash Nickkholgh, Peter Schemmer, Ulf Hinz, Till Gerling, Peter Sauer, Jens Encke, Jürgen Weitz, Markus W. Büchler, Jan Schmidt. Heidelberg, Germany; Leiden, Netherlands.

5:24 PM MAXIMIZING IMPORTATION AND USE OF LOCALLY UNWANTED KIDNEYS. (Abstract #63)
Scott A. Ames, Carrie D. Comellas, Enver Akalin, Lisa B. Vanderbeek, Eric B. Grossman, Jonathan S. Bromberg. New York, NY; Stony Brook, NY, USA

7.) Living Donation

4:00 PM EXPANDED CRITERIA FOR LIVING LIVER DONORS? (Abstract #64)
Burckhardt Ringe, Ralph Petrucci, Tracy Drufovka, David Sass. Philadelphia, PA, USA.

4:12 PM OLDER LIVING DONORS: A BETTER ALTERNATIVE FOR OLDER PATIENTS? (Abstract #65)
Bishoy N. Anastasi, Jagbir Gill, Gabriel M. Danovitch, Suphamai Bunnapradist, Michael Cecka. Los Angeles, CA, USA.

4:24 PM INSURING THE LIVES OF LIVING KIDNEY DONORS AND REVIEW OF COMPICATIONS REPORTED TO THE LIVING ORGAN DONOR NETWORK. (Abstract #66)
Harlan C. Rust, Arlene M. Skinner, Thomas M. McCune. Norfolk, VA; Richmond, VA, USA.

4:36 PM FOLLOW-UP OF KIDNEY DONORS WHO DEVELOPED UREMIA AND WENT ON THE WAITING LIST FOR A TRANSPLANT: SHOULD THEY HAVE ALLOCATION PRIORITY? (Abstract #67)
R.B. Pereira, J. Scheeren, D. Castro, G. Machado, G. Jost, R.K. Mello, T. Zanette, T. Capelletti, V.F. Fonseca, E. Keitel, A.F. Santos, C.D. Garcia, J.J. Bianchini, V.D. Garcia. Porto Alegre, Brazil.

4:48 PM COMPARING POTENTIAL DONOR AND RECIPIENT ATTITUDES REGARDING ABO INCOMPATIBLE TRANSPLANTATION VERSUS PAIRED KIDNEY EXCHANGE. (Abstract #68)
Abbas Rana, Emily Ratner, Donald S. Kornfeld, Ilona Wiener, Victoria Ernst, Lloyd E. Ratner. New York, NY, USA.

5:00 PM EVALUATING LIVING KIDNEY DONORS: RELATIONSHIP TYPES, PSYCHOSOCIAL CRITERIA, AND CONSENT PROCESSES AT U.S. TRANSPLANT PROGRAMS. (Abstract #69)
James R. Rodrigue, Martha Pavlakis, Gabriel M. Danovitch, Scott R. Johnson, Seth J. Karp, Khalid Khwaja, Didier A. Mandelbrot. Boston, MA; Los Angeles, CA, USA.

5:12 PM INTERMEDIATE AND LONG TERM FOLLOW UP OF LIVE RENAL DONORS IN A METROPOLITAN CITY IN SOUTH INDIA. (Abstract #70)
J. Subramanian, Georgi Abraham, P. Soundararajan, S. Suresh, N. Padma. Porur, Chennai, Tamilnadu; Chennai, India.

5:24 PM ENHANCING LIVING DONATION IN CANADA: CONSENSUS RECOMMENDATIONS FROM THE 2006 VANCOUVER FORUM. (Abstract #71)
Kimberly Young, Sandra Cockfield, Tracy Brand, Diane Hébert. Edmonton, AB, Canada.

8.) Professional Education/Hospital Development

4:00 PM ATTITUDES TO ORGAN DONATION: A SURVEY OF CURRENT AND FUTURE UK DOCTORS. (Abstract #72)
Joannis E. Vamvakopoulos, Melpomeni Kountouri, Paul Cockwell. Birmingham, United Kingdom.

4:12 PM IMPROVING THE SUPPLY OF ORGANS FOR TRANSPLANT FROM THE EMERGENCY DEPARTMENT. A RETROSPECTIVE AUDIT OF DEATHS AND EDUCATIONAL DEVELOPMENT STRATEGIES. (Abstract #73)
Paula Mary Aubrey. London; Guildford, United Kingdom.

4:24 PM EXPANDING THE MEDICAL EXAMINER/OPO RELATIONSHIP. (Abstract #74)
Amy Olszewski, Joan Bates, Mara Venners, Richard Pietroski. Ann Arbor, MI, USA.

4:36 PM G.I.V.E: IMPLEMENTING CLINICAL TRIGGERS INTO PRACTICE. (Abstract #75)
Katherine H. Poser. Fredericton, NB, Canada.

4:48 PM A COLLABORATIVE CAMPAIGN TO INITIATING A DCD POLICY IN SOUTHERN CALIFORNIA HOSPITALS. (Abstract #76)
Glenn M. Matsuki, Wanda H. Jones. Los Angeles, CA, USA.

5:00 PM IMPLEMENTING DONATION AFTER CARDIAC DEATH AS PART OF END-OF-LIFE CARE. (Abstract #77)
Judy Kojlak, Michael Sharpe, Frank Rutledge, Susan Williams, Patricia Merrifield, Clare Payne. London; Toronto, Canada.

5:12 PM ATTITUDES TOWARDS DONATION AMONGST CRITICAL CARE STAFF: A SINGLE CENTER ANALYSIS. (Abstract #78)
Beatrice Pelleriaux, Denis Dufrane. Brussels, Belgium.

5:24 PM CONTROVERSY AND CONSENSUS ON PEDIATRIC DCD: CRAFTING ONE HOSPITAL’S POLICY. (Abstract #79)
Charlotte H. Harrison, Peter Laussen. Boston, MA, USA.

5:40 PM – 7:00 PM Poster Session 1: Wine and Cheese Reception
Presenters in attendance

Donor Management

P5 OUTCOME OF LIVING KIDNEY TRANSPLANTATION USING LAPAROSCOPIC NEPHRECTOMY IN SAUDI ARABIA. (Abstract #124)
Issa A. Kawalit, Husain A. Hayati, Adnan Sadeq, Sameh A. Mourad, Saif ElDeen S. Al-Horani, Hani Haider, Said A. Yusuf, Khadija A. AbuDayya. Al-Khobar, Saudi Arabia.

P7 IMPACT OF DONOR KIDNEY RECOVERY METHOD ON LYMPHATIC COMPLICATIONS IN KIDNEY TRANSPLANTATION. (Abstract #126)
Reza F. Saidi, Jason A. Wertheim, Dicken S.C. Ko, Nahel Elias, Hertl Martin,Francis L. Delmonico, A. Benedict Cosimi, Tatsuo Kawai. Boston, MA, USA.

Effective Consent Models/Family Care and Communication

Ethical and Legal Issues of Donor

Expanded Donor Criteria

Minority and Ethnic Organ Donation

Organ Allocation

Organ Preservation

Public and Professional Education

Tissue Banking

2:40 PM – 3:40 PM Oral Abstract Presentations III

9.) Donation After Cardiac Death

2:40 PM EXCELLENT LONG-TERM GRAFT SURVIVAL OF CONSECUTIVE 106 RENAL TRNSPLANTS ENGRAFTING KIDNEYS FROM CARDIAC DEATH DONORS. (Abstract #80)
Kiyotaka Hoshinaga, Hitomi Sasaki, Kunihiro Hayakawa, Takahiro Maruyama, Mamoru Kusaka, Ryoichi Shiroki. Toyoake, Aichi, Japan.

2:52 PM ONE OPOs SUCCESSFUL IMPLEMENTATION OF A DCD PROGRAM RESULTED IN 420 DCDs and 785 ORGANS TRANSPLANTED. (Abstract #81)
H. Nathan, R. Hasz, J. Edwards, J. Abrams, S. West, S. Demczyszyn, G. George. Philadelphia, PA, USA.

3:04 PM A SUCCESSFULL DECADE OF CONTROLLED DONATION AFTER CARDIAC DEATH DONOR (DCD) LIVER TRANSPLANTATION. (Abstract #82)
David J. Reich, Cosme Manzarbeitia, Barbara Aguilar, Adina Osband, Radi Zaki, Mauricio Orrego, Victor Araya, Kenneth Rothstein, Santiago Munoz. Philadelphia, PA, USA.

3:16 PM INTRODUCING DONATION AFTER CARDIAC DEATH THE CANADIAN WAY. (Abstract #83)
Frank M. Markel, Clare Payne. Toronto, ON, Canada.

3:28 PM INTRODUCTION OF A DECEASED CARDIAC DONOR PROGRAMME IN THE UK. (Abstract #84)
Sharon B. Carey, Martin B. Walker. Plymouth, United Kingdom.

10.) Tissue Banking

2:40 PM DECEASED TISSUE DONATION: (TO WHAT EXTENT) SHOULD WE MODIFY CONSENT PROCEDURES TO INCREASE DONATION RATES? (Abstract #85)
Lisa Dinhofer, Annette Schulz-Baldes. Frederick, MD; Bethesda, MD, USA; Zurich, Switzerland.

2:52 PM REDUCTION OF CATEGORY 3 ORGANISM GROWTH IN RECOVERY CULTURES OF POST-AUTOPSY DONORS BY AN ABDOMINAL CAVITY PREP. (Abstract #86)
Susan Cohrs, Ken Blair, David Smith. Dayton, OH, USA.

3:04 PM IMPROVEMENT MEASURES TO INCREASE TISSUE DONATION – LESSONS FROM TWO UNIVERSITY HOSPITALS IN BELGIUM AND SPAIN. (Abstract #87)
Beatrice Pelleriaux, Denis Dufrane. Brussels, Belgium.

3:16 PM STUDY OF USEFULNESS OF EYE DONATION IN RELATION WITH DEATH TO ENUCLEATION TIME (DET). (Abstract #88)
Aarti Vij, M. Kumath, S. Lalwani, R. Tandon. New Delhi, Delhi, India.

3:28 PM THE EFFECTS OF RECOVERY SITE ON MICROBIOLOGIC CULTURE RESULTS. (Abstract #89)
Reg Dawson, Ann Lay, David Smith. Toledo, OH; Dayton, OH, USA.

11.) Organ Preservation

2:40 PM IMPACT OF PULSATILE PERFUSION ON TRANSPLANTS FROM DECEASED DONOR AFTER CARDIAC DEATH: AN OPTN/UNOS ANALYSIS. (Abstract #90)
Bishoy N. Anastasi, Jagbir Gill, Gabriel M. Danovitch, Yuk-Chor Wong, Tariq Shah, Suphamai Bunnapradist. Los Angeles, CA, USA.

3:04 PM THE USE OF LAZAROID U-74389G REDUCES ISCHEMIA-REPERFUSION INJURY IN EXPERIMENTAL LUNG TRANSPLANTATION. (Abstract #92)
Apostolos Papalois, Panayiotis Dedeilias, Efstratios Koletsis, Efstratios Apostolakis, Maria Chorti, Varvara Sfyra, Aikaterini Pseudi, Constantine Bolos. Pikermi, Athens; Athens; Patras, Achaia; Melissia, Athens, Greece.

3:16 PM IN SITU PROCUREMENT FLUSH WITH LACTATED RINGER’S SOLUTION IMPROVES OUTCOMES AND DECREASES COST IN ADULT LIVER TRANSPLANTATION. (Abstract #93)
M.A. Jafri, M. Lucia, C. Andrews, A.D. Tevar, E. Steve Woodle, S.M. Rudich. Cincinnati, OH, USA.

3:28 PM THE EFFECT OF THE INTRALUMINAL DELIVERY OF MACROMOLECULAR SOLUTIONS ON THE INTESTINAL PRESERVATION INJURY. (Abstract #94)
Mihai Oltean, Gustaf Herlenius, Anne Floden, Markus Gäbel, Michael Olausson. Göteborg, Sweden.

3:40 PM LONG TERM BENEFITS OF PERFUSION KIDNEY STORAGE BEFORE TRANSPLANTATION. (Abstract #94.5)
Artur Kwiatkowski, Michal Wszola, Maciej Kosieradzki, Agnieszka Perkowska-Ptasinska, Roman Danielewicz, Krzysztof Ostrowski, Wojciech Lisik, Janusz Trzebicki, Piotr Domagala, Magda Durlik, Leszek Paczek, Andrzej Chmura, Wojciech Rowinski. Warsaw, Poland.

12.) Donation Improvement Models

2:40 PM SUCCESSFUL IMPLEMENTATION OF OPO-BASED ORGAN AND TISSUE RECOVERY SUITES. (Abstract #95)
H. Nathan, R. Hasz, S. Demczyszyn, C. Radolovic, T. Snyder, R. Jones, R. Ryan, S. West. Philadelphia, PA, USA.

2:52 PM A 16-FOLD INCREASE IN ORGAN DONATION IN A HISPANIC POPULATION. (Abstract #96)
Eduardo A. Santiago, Marien Saade, Luis A. Morales, Zulma A. Gonzalez, Jean Davis, Esther Torres. Hato Rey, PR; San Juan, PR.

3:04 PM MEASURING ORGAN DONATION PERFORMANCE INTERNATIONALLY: MODELING THE EFFECTS OF AVAILABLE DENOMINATORS FOR ORGAN DONATION RATES. (Abstract #97)
Karen Hornby, Ivan B. Pless, Sam Shemie. Montreal, QC, Canada.

3:16 PM CONVERTING FAMILY ADVOCATES TO LEVEL I RECOVERY COORDINATORS. (Abstract #98)
Cammie M. Caillouet-O’Neal, Quentin G. Booker. Baton Rouge, LA, USA.

3:28 PM COMMITTING RESOURCES TO THE RETENTION OF HIGHLY SKILLED TRANSPLANT COORDINATORS ADVANCES BOTH THE MISSION OF ORGAN AND TISSUE DONATION AND RESULTS IN COST SAVINGS AS COMPARED TO HIRING AND TRAINING OF REPLACEMENT STAFF. (Abstract #99)
Keith B. Klasic, Jan L. Weinstock, Howard M. Nathan. Philadelphia, USA.

Donation after Cardiac Death (DCD)

Donor Management

Donor Registries

Economics of Donation

Effective Consent Models/Family Care and Communication

Ethical and Legal Issues of Donor

Financial Incentives

Organ Allocation

Organ Preservation

Public and Professional Education

Successful Improvement Models

Tissue Banking

4:50 PM – 6:00 PM Oral Abstract Presentations IV

13.) Donation After Cardiac Death

4:50 PM MACHINE PERFUSION AS A TOOL FOR SELECTION AND RECOVERING OF KIDNEYS FROM UNCONTROLLED DONORS AFTER CARDIAC DEATH. (Abstract #100)
Oleg N. Reznik, Sergey F. Bagnenko, Yan G. Moisiuk, Igor V. Loginov, Alexey N. Ananyev, Sergey V. Eremich, Victoria A. Iljina. Saint-Petersburg; Moscow, Russian Federation.

5:02 PM OPO EXPERIENCE WITH NON-NEUROLOGICAL INJURIES INCREASES DONATION AFTER CARDIAC DEATH DONORS AND ORGANS FOR TRANSPLANTATION. (Abstract #101)
Judy M. Ferrarie, Gweneth D. George, Richard D. Hasz, Howard M. Nathan. Philadelphia, USA.

5:14 PM ARE WE READY TO UTILIZE NON-HEART-BEATING DONOR FOR CLINICAL ALLOTRANSPLANTATION IN CHINA? (Abstract #102)
Zidong Liu, Ping Yun, He Xu. Jinan, Shandong, China.

5:26 PM DONATION AFTER CARDIAC DEATH: CONSENSUS RECOMMENDATIONS FROM THE 2005 VANCOUVER FORUM. (Abstract #103)
Kimberly Young, Sam Shemie, Christopher Doig. Edmonton, AB, Canada.

5:38 PM EMPOWERING THE POWERLESS WITH LIFE IN DEATH. (Abstract #104)
Hedi Aguiar, Tasha R. Querantes, Esther C. Montoya, Maria Stadtler, Tom Mone, Esther-Marie Carmichael. Los Angeles, CA, USA.

14.) Donor Management

4:50 PM CORONARY ANGIOGRAPHY IN HEART DONORS: NECESSITY OR LUXURY? (Abstract #105)
Frank Polster, Gunther Schmidt, Martina de la Chevallerie, Ronald Krueger, Onnen Grauhan, Roland Hetzer, Claus Wesslau. Berlin, Germany.

5:02 PM 3 YEARS OF QUALITY MANAGEMENT INCREASED THE NUMBER OF TRANSPLANTED ORGANS IN A GERMAN ORGAN DONATION REGION. (Abstract #106)
Monika Schmid, Kerstin Moench, Dietmar Mauer. Mainz, Germany.

5:14 PM THE TRANSCRIPTOME OF THE IMPLANT BIOPSY IDENTIFIES DONOR KIDNEYS AT INCREASED RISK OF DELAYED GRAFT FUNCTION. (Abstract #107)
Thomas F. Mueller, Gian S. Jhangri, Jeff Reeve, Michael Mengel, Philip F. Halloran. Edmonton, AB, Canada.

5:26 PM TUMOR NECROSIS FACTOR GENOTYPE OF THE DECEASED DONOR KIDNEYS ASSOCIATED WITH DELAYED ALLOGRAFT FUNCTION (DGF). (Abstract #108)
Ajay K. Israni, Na Li, Bojana B. Cizman, Jon Snyder, John Abrams, Marshall Joffe, Timothy Rebbeck, Harold Feldman. Minneapolis, MN; Philadelphia, PA, USA.

5:38 PM STANDARDIZATION OF HORMONAL RESUSCITATION TO ENTIRE POOL OF BRAIN DEAD DONORS INCREASES ORGANS TRANSPLANTED PER DONOR. (Abstract #109)
Tina M. Abdelnour, Steve Rieke. St. Paul, MN, USA.

15.) Public Education & Opinion

4:50 PM IMPLEMEMATION OF DRIVER’S LICENSE DONOR REGISTRIES ENHANCES ORGAN DONATION. (Abstract #110)
John Green, Jan Weinstock, Rick Hasz, Sharon West, Howard Nathan. Philadelphia, PA, USA.

5:02 PM FINANCIAL INCENTIVES: THE OPO COORDINATOR’S PERSPECTIVE. (Abstract #111)
Shirley Schlessinger, Kevin Stump. Jackson, MS, USA.

5:14 PM ALTRUISM AND FINANCIAL INCENTIVES: FAMILY EXPERIENCES OF DECEASED DONORS. (Abstract #112)
Bartira de Aguiar Roza, Janine Schirmer. Sao Paulo, Brazil.

5:26 PM ATTITUDE AND AWARENESS TO ORGAN DONATION IN SCHOOL CHILDREN – A CRITICAL ANALYSIS. (Abstract #113)
Thomas Winston Athisayaraj, Neil Frude, Jill Fizgibbon, Alex Faulkner, Nagappan Kumar. Cardiff, Wales; Cardiff, South Wales, United Kingdom.

5:38 PM SCHOOL EDUCATION ON ORGAN TRANSPLANTATION. (Abstract #114)
Felix Cantarovich, Marcelo Cantarovich, Ruben Revello, Lyz Falco, Christophe Legendre. Paris, France; Buenos Aires, Argentina; Montreal, Canada.

16.) Pancreas & Small Bowel

4:50 PM LONG TERM OUTCOMES OF INTESTINAL TRANSPLANTATION FROM DONORS UNDER AGE 1. (Abstract #115)
Zurab Machaidze, Geoffrey Bond, Kyle Soltys, Rakesh Sindhi, Dolly Martin, Graciela Perez, Kareem Abu Elmagd, George Mazariegos. Pittsburgh, PA, USA.

5:02 PM COMPARISON OF HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) AND UNIVERSITY OF WISCONSIN (UW) SOLUTIONS IN BOWEL TRANSPLANTATION. (Abstract #116)
Richard S. Mangus, Rodrigo M. Vianna, A. Joseph Tector, Sam Popa, Jonathan A. Fridell. Indianapolis, IN, USA.

5:14 PM PANCREAS DONORS: UNDERUTILIZATION OR POTENTIAL OVERESTIMATION? (Abstract #117)
Carl-Ludwig Fischer-Fröhlich, Werner Lauchart, Wolfgang Steurer. Stuttgart; Tuebingen, Germany.

5:26 PM PANCREATIC TRANSPLANTATION USING EXTENDED CRITERIA DONORS. (Abstract #118)
Rajinder P. Singh, Jeffrey Rogers, Alan Farney, Philip S. Moore, Erica L. Hartmann, Amber Reeves-Daniel, Patricia L. Adams, Michael Gautreaux, Robert J. Stratta. Winston-Salem, NC, USA

5:38 PM REGRESSION ANALYSIS OF PANCREAS ALLOGRAFT SURVIVAL AT A SINGLE CENTER. (Abstract #119)
Richard S. Mangus, John A. Powelson, Elaine Mohler, Jonathan A. Fridell. Indianapolis, IN, USA.

12:45 PM Adjourn

Back to Top